CIK 0001775194 · Non-accelerated filer<br>Smaller reporting company
UPEXI, INC.
Sign in to watch- Ticker
- UPXI
- Exchange
- Nasdaq
- Industry
- Finance Services
- FY end
- Jun 30
- Incorporated
- DE
- Entity type
- operating
- EIN
- 833378978
- Phone
- 727-287-2800
- Business address
- 3030 N. ROCKY POINT DRIVE, SUITE 420, TAMPA, FL
- Former names
- GROVE, INC.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-07-03 | Dugan Lawrence Director | Grant or award | +100,000 | 220,389 | ||
| 2026-07-03 | Williams Thomas Charles Director | Grant or award | +100,000 | 200,000 | ||
| 2026-07-03 | Salkind Gene Director | Grant or award | +100,000 | 318,750 | ||
| 2026-07-03 | Dugan Lawrence Director | Grant or award | +100,000 | 216,389 | ||
| 2026-07-03 | Rudick Brian Benjamin Chief Strategy Officer | Grant or award | +400,000 | 1,238,597 | ||
| 2026-07-03 | MARSHALL ALLAN Chief Executive Officer | Grant or award | +2,000,000 | 6,046,261 | ||
| 2026-07-03 | Norstrud Andrew James Chief Financial Officer | Grant or award | +400,000 | 1,049,138 | ||
| 2026-04-28 | Dugan Lawrence Director | Grant or award | +4,000 | $1.30 | $5K | 120,389 |
| 2025-12-23 | MARSHALL ALLAN Chief Executive Officer | Purchase | +50,000 | $1.80 | $90K | 4,046,261 |
| 2025-12-16 | MARSHALL ALLAN Chief Executive Officer | Purchase | +50,000 | $2.07 | $104K | 3,996,261 |
| 2025-12-15 | MARSHALL ALLAN Chief Executive Officer | Purchase | +100,000 | $2.07 | $207K | 3,946,261 |
| 2025-11-20 | Salkind Gene Director | Purchase | +50,000 | $2.55 | $128K | 218,750 |
| 2025-11-17 | Salkind Gene Director | Purchase | +100,000 | $2.65 | $265K | 569,470 |
| 2025-11-17 | Salkind Gene Director | Purchase | +100,000 | $2.81 | $281K | 168,750 |
| 2025-10-01 | MARSHALL ALLAN Chief Executive Officer | Grant or award | +1,600,000 | 3,846,261 | ||
| 2025-10-01 | Norstrud Andrew James Chief Financial Officer | Grant or award | +240,000 | |||
| 2025-07-22 | Dugan Lawrence Director | Purchase | +4,000 | $7.50 | $30K | 116,389 |
| 2025-07-16 | Salkind Gene Director | Grant or award | +50,000 | 435,370 | ||
| 2025-07-16 | Salkind Gene Director | Grant or award | +150,000 | 585,370 | ||
| 2025-07-16 | Rudick Brian Benjamin CSO | Grant or award | +400,000 | 838,597 |
Page 1 of 4 · 74 trades